Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy
Jean‐Louis Vincent(Université Libre de Bruxelles), Mradul Kumar Daga(Maulana Azad Medical College), Jawed Fareed(Loyola University Chicago), Kenneth J. Gorelick, Ville Pettilä(University of Helsinki), Steven M. Opal(Brown University), Philip S. Barie(Université Paris Cité), Marcel Levi(University College London Hospitals NHS Foundation Trust), Satoshi Gando(Sapporo University), Hidehiko Saito(Seirei Hamamatsu General Hospital), Suzana Margareth Lobo(Faculdade de Medicina de São José do Rio Preto), Xavier Wittebole(Cliniques Universitaires Saint-Luc), Jean-Baptiste Lascarrou(Centre Hospitalier Universitaire de Nantes), Mark Crowther(Population Health Research Institute), Takumi Sakai(Asahi Kasei (Japan)), И. Б. Заболотских(Kuban State Medical University), Bruno François(Inserm), Charles T. Esmon(Howard Hughes Medical Institute), Ferhat Meziani(Université de Strasbourg), Jean-Paul Mira(Sorbonne Paris Cité), James A. Russell(University of British Columbia), David Fineberg(Asahi Kasei (United States)), Emmanuelle Mercier(Centre Hospitalier Universitaire de Tours), Joseph E. Parrillo(Hackensack University Medical Center), М. Yu. Кirov(Northern State Medical University), Kazuhisa Tsuruta(Asahi Kasei (Japan))
Cited by 370
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure
|Intensive Care Medicine|1996|11.7k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
|New England Journal of Medicine|2001|6.1k